Thermo Fisher Scientific Inc. (VIE:TMOF)

Market Cap	181.31B -12.8%
Revenue (ttm)	37.95B +3.9%
Net Income	5.71B +5.8%
EPS	15.11 +7.3%
Shares Out	n/a
PE Ratio	31.75
Forward PE	23.29
Dividend	1.50 (0.31%)
Ex-Dividend Date	Dec 15, 2025

Volume	n/a
Average Volume	1
Open	483.35
Previous Close	490.95
Day's Range	483.35 - 483.65
52-Week Range	338.30 - 578.50
Beta	n/a
RSI	37.44
Earnings Date	Jan 29, 2026

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company’s Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery and production of drugs and vaccines, as well as diagnosis of infections and diseases. Its Analytical Instruments segment provides instruments, consumables, software, and services for phar...

• Industry: Laboratory Analytical Instruments
• Founded: 1956
• Employees: 125,000
• Stock Exchange: Vienna Stock Exchange
• Ticker Symbol: TMOF

Financial Performance

In 2025, Thermo Fisher Scientific's revenue was $44.56 billion, an increase of 3.91% compared to the previous year's $42.88 billion. Earnings were $6.70 billion, an increase of 5.82%.

Financial numbers in USD